# Eflornithine With or Without Triamcinolone in Preventing Nonmelanoma Skin Cancer in Patients With Actinic Keratosis

> **NCT00021294** · PHASE2 · COMPLETED · sponsor: **University of Arizona**

## Conditions studied

- Non-melanomatous Skin Cancer
- Precancerous/Nonmalignant Condition

## Interventions

- **DRUG:** eflornithine
- **DRUG:** triamcinolone

## Key facts

- **NCT ID:** NCT00021294
- **Lead sponsor:** University of Arizona
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-05
- **Primary completion:** 2002-06
- **Final completion:** 2002-06
- **Target enrollment:** — (—)
- **Last updated:** 2018-09-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00021294

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00021294, "Eflornithine With or Without Triamcinolone in Preventing Nonmelanoma Skin Cancer in Patients With Actinic Keratosis". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00021294. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*